Hormonal
Berberine administration reduces oxidative stress and inflammation in diabetic models by activating AMPK, Nrf2, and inhibiting NF-κB and MAPK pathways, thereby improving insulin sensitivity and reducing complications.
Berberine appears to help manage Type 2 Diabetes by reducing inflammation and oxidative stress. It works by activating AMPK, similar to how exercise or metformin might. While animal studies show strong effects, human clinical data is limited but promising. Consult a doctor before use, especially if taking other medications.
Recent studies showed that BBR had beneficial effects on cellular oxidative stress and inflammation, which could also play important roles in its activity against diabetes mellitus. Mechanisms of BBR in restoring insulin sensitivity and lowering blood glucose included inhibition of mitochondrial function and activation of AMP-activated protein kinase (AMPK)... Recent studies showed that BBR had beneficial effects on cellular oxidative stress and inflammation...
Why this rating
The paper is a review of animal and cell studies; clinical data is mentioned but limited in scope (e.g., one study cited for IL-6 reduction).
Source
Antioxidant and Anti‐Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Zheng Li et al. · Evidence-based Complementary and Alternative Medicine · 2014
DOI 10.1155/2014/289264
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →